Healthcare Most Active – Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ)

Jacobs Engineering Group Inc. (NYSE:JEC) announced a collaboration with Pfizer Inc. (NYSE:PFE) on a modular process system to address the rapidly changing requirements of localized pharmaceutical manufacturing in emerging market countries. Pfizer Inc. (NYSE:PFE) stock opened at $31.03 in last session, and closed at $30.60, while the day range of PFE stock is $30.57 – $31.69. The stock showed a positive weekly performance of 3.17%.

Merck & Co Inc (NYSE:MRK) was upgraded by stock analysts at SunTrust from a “neutral” rating to a “buy” rating in a report issued on Tuesday. Merck & Co., Inc. (NYSE:MRK) stock opened at $52.91, in last session and closed at $52.08, by losing -1.68%. The 52 week range of MRK is $40.83 – $54.10. Company’s market capitalization is $152.42billion.

Gilead Sciences Inc (NASDAQ:GILD) was upgraded by equities research analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating in a research note issued to investors on Tuesday. Gilead Sciences, Inc. (NASDAQ:GILD) stock decreased -2.26% and finished the last session at $78.883. The EPS of the stock remained 1.55. Company’s market capitalization is $120.87billion.

In a move that promotes open science, Johnson & Johnson (NYSE:JNJ) announced last week that it will make all of its clinical trial data publicly available. Johnson & Johnson (NYSE:JNJ) stock opened the session at $88.75, and closed the session at $86.78. The 52 week range of the JNJ stock remained $73.56 – $95.99 and the day range was $86.61 – $88.78.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *